TLR5 agonist

SAN ANTONIO, Texas, July 14, 2026 Valion Bio, Inc. has announced major strategic progress across its Entolimod platform, advancing...

San Antonio, Texas, March 26, 2026 In a strategic move to address critical gaps in radiation emergency therapeutics, Tivic...